Coronavirus vaccines can reduce disease severity and fatality, but the emergence of new strains has raised questions about their effectiveness and future vaccination strategy. Some vaccine makers are rolling out variant-specific boosters to head off the Omicron surge, while others are developing pan-coronavirus vaccines that will hopefully offer protection against all variants.
The partners are jointly pursuing the goal to establish a fully digitalized solution to be used by major banks and invoice issuers in selected European markets for invoice issuing and payments processing.